Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen
Met Antibody | Cell Signaling Technology
They Should Be in Jail': Nan Goldin, Anti-Sackler Opioid Activists Take Fight to Guggenheim, Met – ARTnews.com
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
Met (c Met) Polyclonal Antibody – Bioss
Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM | PNAS
Met (c Met) Polyclonal Antibody – Bioss
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
Anti-MET Antibody (PACO01060) | WB
Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
JPM | Free Full-Text | MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine
c-Met Monoclonal Antibody (3D4) (18-7366)
InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell
IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain
7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram
Biomedicines | Free Full-Text | Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy
c-Met Polyclonal Antibody (PA5-85951)
Anti-c-Met antibody
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering | Scientific Reports